These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3555419)
1. Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health. Reddy JK; Rao MS Arch Toxicol Suppl; 1987; 10():43-53. PubMed ID: 3555419 [TBL] [Abstract][Full Text] [Related]
2. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237 [TBL] [Abstract][Full Text] [Related]
3. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fischer-344 rats. Tamura H; Iida T; Watanabe T; Suga T Toxicology; 1990 Aug; 63(2):199-213. PubMed ID: 2399535 [TBL] [Abstract][Full Text] [Related]
5. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Melnick RL Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792 [TBL] [Abstract][Full Text] [Related]
7. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618 [TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Yeldandi AV; Rao MS; Reddy JK Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470 [TBL] [Abstract][Full Text] [Related]
9. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Reddy JK; Rao MS Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702 [TBL] [Abstract][Full Text] [Related]
10. PPAR: a mediator of peroxisome proliferator action. Green S Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617 [TBL] [Abstract][Full Text] [Related]
11. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Tamura H; Iida T; Watanabe T; Suga T Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188 [TBL] [Abstract][Full Text] [Related]
12. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610 [TBL] [Abstract][Full Text] [Related]
13. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Tomaszewski KE; Agarwal DK; Melnick RL Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136 [TBL] [Abstract][Full Text] [Related]
14. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680 [TBL] [Abstract][Full Text] [Related]
15. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate. Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y Cancer Lett; 1990 Aug; 53(1):33-8. PubMed ID: 2397479 [TBL] [Abstract][Full Text] [Related]
16. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Huber WW; Grasl-Kraupp B; Schulte-Hermann R Crit Rev Toxicol; 1996 Jun; 26(4):365-481. PubMed ID: 8817083 [TBL] [Abstract][Full Text] [Related]
17. [Proliferation of peroxisomes and the hepatocarcinogenic process]. Palut D Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657 [TBL] [Abstract][Full Text] [Related]
18. Transformation of epithelial cells stably transfected with H2O2-generating peroxisomal urate oxidase. Chu R; Lin Y; Reddy KC; Pan J; Rao MS; Reddy JK; Yeldandi AV Cancer Res; 1996 Nov; 56(21):4846-52. PubMed ID: 8895731 [TBL] [Abstract][Full Text] [Related]
19. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Lalwani ND; Reddy MK; Qureshi SA; Reddy JK Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344 [TBL] [Abstract][Full Text] [Related]
20. Hepatic peroxisome proliferation in rodents and its significance for humans. Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]